A cornerstone of the global initiative to eradicate polio is the widespread use of live and
inactivated poliovirus vaccines in extensive public health campaigns designed to prevent …

Introduction The polio eradication endgame strategic plan calls for the sequential removal of
Sabin poliovirus serotypes from the trivalent oral poliovirus vaccine (tOPV), starting with type …

Background Novel oral poliovirus vaccine type 2 (nOPV2) was used to control an outbreak
of type 2 circulating vaccine derived poliovirus (cVDPV2) in Tajikistan, in 2021. We …

African swine fever (ASF) is currently the major concern of the global swine industry, as a
consequence of which a reconsideration of the containment and prevention measures taken …

Background Replacement of the trivalent oral poliovirus vaccine (tOPV) with bivalent types 1
and 3 oral poliovirus vaccine (bOPV) and global introduction of inactivated poliovirus …

Background Following the global eradication of wild poliovirus, countries using live
attenuated oral poliovirus vaccines will transition to exclusive use of inactivated poliovirus …

Background Intradermal administration of fractional inactivated poliovirus vaccine (fIPV) is a
dose-sparing alternative to the intramuscular full dose. We aimed to compare the …

This narrative review is the final output of an initiative of the SIM (Italian Society of
Mesotherapy). A narrative review of scientific literature on the efficacy of fractional …

Background The polio eradication endgame required the withdrawal of Sabin type 2 from
the oral poliovirus vaccine and introduction of one or more dose of inactivated poliovirus …

In May 2016, countries using oral polio vaccine for routine immunization switched from
trivalent oral poliovirus vaccine (tOPV) to bivalent type 1 and 3 OPV (bOPV). This was done …